You are here

The Progress Report Progress never stops. Stay informed with the latest news on breast cancer research, treatment, and prevention.


SABCS 2015 x

The last full day of SABCS 2015 started with a discussion on the past and future directions of HER2- directed therapies. In his lecture, Dr.

The third day of the San Antonio Breast Cancer Symposium began with a plenary session on tumor heterogeneity – a term that refers to the extensive genetic variability of breast cancers.

A team of Yale researchers has discovered a new complexity in drug resistance that may lead to the development of future therapies for patients with HER2-positive breast cancer.